Peter Vozzo | Investor Relations |
Neil McFarlane | Chief Executive Officer |
Vijay Shreedhar | Chief Commercial Officer |
Chris Prentiss | Chief Financial Officer |
Adrian Quartel | Chief Medical Officer |
Jason Butler | JMP Securities |
Ken Cacciatore | Cowen |
Marc Goodman | SVB Leerink |
David Amsellem | Piper Sandler |
Greetings and welcome to the Adamas Pharmaceuticals Second Quarter 2021 Financial Results and Corporate Update Conference Call. At this time all participates are in a listen-only mode. [Operator Instructions] I would now like to turn the call over to Peter Vozzo, Investor Relations representative for Adamas Pharmaceuticals. Please go ahead sir.
Thank you, Michelle, and good afternoon, everyone.